Use of pla2 inhibitors as treatment for alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/41 (2006.01) A61K 31/00 (2006.01) A61K 31/165 (2006.01) A61K 31/18 (2006.01) A61K 31/19 (2006.01) A61K 31/35 (2006.01)

Patent

CA 2179649

This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A2. This invention also provides a series of compounds which are useful as inhibitors of phospholipases A2, especially cytosolic phospholipase A2.

L'invention se rapporte à des procédés de traitement ou de prévention de la maladie d'Alzheimer chez un mammifère, ce procédé consistant à administrer à un mammifère nécessitant un tel traitement une dose efficace d'un inhibiteur de phospholipase A¿2? (PLA¿2?). L'invention se rapporte également à une série de composés aptes à être utilisés comme inhibiteurs de phospholipases A¿2?, en particulier de la phospholipase A¿2? cytosolique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of pla2 inhibitors as treatment for alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pla2 inhibitors as treatment for alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pla2 inhibitors as treatment for alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1907042

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.